Please login to the form below

Not currently logged in
Email:
Password:

Novo Holdings

This page shows the latest Novo Holdings news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Global Blood confident of sickle cell success, Breathalyser wins engineering award, Swiss biotech raises funds

Daily brief: Global Blood confident of sickle cell success, Breathalyser wins engineering award, Swiss biotech raises funds

Novo Holdings financed the company, and together with an earlier boost of CHF 20m, the group’s total has reached CHF 40m.

Latest news

  • Novo launches $165m antimicrobial resistance initiative Novo launches $165m antimicrobial resistance initiative

    The REPAIR fund is the brainchild of Novo Holdings, the major shareholder in the Novo Group companies and will focus on priority pathogens, which the World Health Organization (WHO) defines as ... Kasim Kutay, chief executive officer of Novo Holdings,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    These initiatives have been recently joined by a $165m ‘REPAIR’fund from Novo Holdings, as an investment in companies involved in discovery and early-stage development of therapies to combat antimicrobial

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    2. and CKD. 3. 198. Zosano (formerly Macroflux) / Novo Nordisk. ... UDG subsidiaries : The Specials Laboratory Holdings, Craig &Hayward, Arjun Products.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics